Enliven Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29337E1029
USD
31.15
2.12 (7.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryEnliven Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
7.3%
1.15%
1W
13.73%
-1.77%
1M
13.48%
-3.75%
YTD
102.27%
-3.86%
1Y
47.77%
16.12%
3Y
38.44%
66.66%
5Y
-15.45%
68.29%
10Y
%
223.12%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
88.45%
0%
88.45%
6 Months
62.32%
0%
62.32%
1 Year
47.77%
0%
47.77%
2 Years
68.56%
0%
68.56%
3 Years
38.44%
0%
38.44%
4 Years
289.38%
0%
289.38%
5 Years
-15.45%
0%
-15.45%

Enliven Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary